Journal
CLINICAL INFECTIOUS DISEASES
Volume 71, Issue 15, Pages 713-720Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa203
Keywords
SARS-CoV-2; COVID-19; intrahost variant; microbiota; transmission
Categories
Funding
- Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [2016-I2M-1-014]
- National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases in China [2017ZX10103004, 2018ZX10305409, 2018ZX10301401, 2018ZX10732401]
- National Natural Science Foundation of China [31670169]
- Open Project of Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences
Ask authors/readers for more resources
Background. A novel coronavirus (CoV), severe acute respiratory syndrome (SARS)-CoV-2, has infected >75 000 individuals and spread to >20 countries. It is still unclear how fast the virus evolved and how it interacts with other microorganisms in the lung. Methods. We have conducted metatranscriptome sequencing for bronchoalveolar lavage fluid samples from 8 patients with SARS-CoV-2, and also analyzed data from 25 patients with community-acquired pneumonia (CAP), and 20 healthy controls for comparison. Results. The median number of intrahost variants was 1-4 in SARS-CoV-2-infected patients, ranged from 0 to 51 in different samples. The distribution of variants on genes was similar to those observed in the population data. However, very few intrahost variants were observed in the population as polymorphisms, implying either a bottleneck or purifying selection involved in the transmission of the virus, or a consequence of the limited diversity represented in the current polymorphism data. Although current evidence did not support the transmission of intrahost variants in a possible person-to-person spread, the risk should not be overlooked. Microbiotas in SARS-CoV-2-infected patients were similar to those in CAP, either dominated by the pathogens or with elevated levels of oral and upper respiratory commensal bacteria. Conclusion. SARS-CoV-2 evolves in vivo after infection, which may affect its virulence, infectivity, and transmissibility. Although how the intrahost variant spreads in the population is still elusive, it is necessary to strengthen the surveillance of the viral evolution in the population and associated clinical changes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available